Clinical studies showed that patients with meningococcemia or hemorrhage due to trauma who received Neuprex ® had no toxic side effects and showed a trend toward improved outcomes, i.e., reduced bone marrow aplasia and deaths ( Demetriades et al., 1999 ; Guinan et al., 2011 ).
← all excerpts
Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs).
1
—
—